Table 2.
MICs (v/v%) against CD2, CD1006, and CD1412.
| Treatmenta | Phytochemical | Nanocomposites (NCs) | ||||
|---|---|---|---|---|---|---|
| CD2 | CD1006 | CD1412 | CD2 | CD1006 | CD1412 | |
| E. coli | P. aeruginosa | E. cloacae complex | E. coli | P. aeruginosa E. | cloacae complex | |
| Eugenol | 16 | 16 | 16 | 4 | 4 | 4 |
| Linalool | >32 | >32 | >32 | 2 | 8 | 8 |
| Methyl eugenol | >32 | >32 | >32 | 4 | 2 | 4 |
| Carvacrol | 16 | 16 | 16 | 4 | 4 | 2 |
| p-cymene | >32 | >32 | >32 | 4 | 4 | 4 |
| (+)-limonene | 32 | 32 | >32 | 2 | 2 | 8 |
| α-pinene | >32 | >32 | >32 | 2 | 4 | 4 |
| Colistin | 1 mg/L | 1 mg/L | 1 mg/L | -- | -- | -- |
a
Bacteria were treated with phytochemical dissolved in 5 v/v% DMSO aqueous solution or NCs. Colistin was used as control. MIC experiments were performed in M9 minimal medium.